© Copyright ClearPath Benefits

Breast Cancer Drugs

Originally posted January 17, 2014 by United Benefit Advisors (UBA)

Starting next September, women at increased risk for breast cancer will be able to get some drugs shown to help prevent the disease without a copay, the Obama administration said Thursday. The U.S. Preventive Services Task Force recommended last September that clinicians give medications such as tamoxifen or raloxifene to such women to reduce their risk of the disease. Under the Patient Protection and Affordable Care Act (PPACA), items or services rated A or B by the independent review board of physicians and academics must be covered by insurers without a copay or deductible. Insurers are given a year to make the change.